Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-01-01

Clinical Trial Update: Economic Impact of Switching From Metoprolol to Nebivolol for Hypertension Treatment

View source ↗

Summary

A clinical trial update examining the economic impact of switching from metoprolol to nebivolol for treating hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BYSTOLIC (nebivolol hydrochloride)
  • METOPROLOL (METOPROLOL TARTRATE)

Snippet

Sponsor: Forest Laboratories | Conditions: Hypertension | Status: UNKNOWN